RPEP2

Across TCGA pan-cancer cohorts, RPEP2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RPEP2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPEP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPEP2 expression acts as an unfavorable survival marker.

STAD, ESCA, and DLBC are the cancer types where RPEP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.513	0.732	.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
TGCT	DFS	Tertile	All	0.059	0.802	<.001	18	view →
BRCA	DFS	Tertile	All	0.724	0.903	.031	12	view →
LUSC	OS	Tertile	All	0.372	0.677	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RPEP2–STAD (OS)

Open the STAD breakdown →